Collegium: Fuller & Thaler reports 1.84% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
For Collegium Pharmaceutical, Inc. (COLL), Fuller & Thaler Asset Management, Inc. reported beneficial ownership of 598,540.14 common shares as of September 30, 2026, equal to 1.84% of the class. The reporting person reported sole voting and sole dispositive power over that position, with shared voting and dispositive power each at 0, and identified its ownership as 5% or less.
Key Figures
Key Terms
Beneficially Owned financial
Sole Voting Power financial
Sole Dispositive Power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.